Jane Street’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.93M Buy
39,800
+2,800
+8% +$698K ﹤0.01% 2676
2025
Q4
$8.91M Sell
37,000
-10,100
-21% -$2.58M ﹤0.01% 2462
2025
Q3
$12.9M Buy
47,100
+11,400
+32% +$3.11M ﹤0.01% 2100
2025
Q2
$9.21M Buy
35,700
+31,200
+693% +$7.44M ﹤0.01% 2246
2025
Q1
$1.01M Sell
4,500
-17,400
-79% -$4.06M ﹤0.01% 5560
2024
Q4
$5.01M Sell
21,900
-10,200
-32% -$2.46M ﹤0.01% 2658
2024
Q3
$7.84M Sell
32,100
-13,200
-29% -$2.95M ﹤0.01% 2202
2024
Q2
$8.67M Sell
45,300
-34,900
-44% -$7.08M ﹤0.01% 2206
2024
Q1
$15.9M Buy
80,200
+66,800
+499% +$12.2M ﹤0.01% 1380
2023
Q4
$2.31M Sell
13,400
-11,900
-47% -$1.83M ﹤0.01% 4083
2023
Q3
$3.74M Buy
25,300
+23,400
+1,232% +$4.23M ﹤0.01% 3026
2023
Q2
$415K Buy
1,900
+100
+6% +$22.3K ﹤0.01% 6604
2023
Q1
$394K Sell
1,800
-4,000
-69% -$868K ﹤0.01% 6737
2022
Q4
$1.21M Buy
+5,800
New +$1.27M ﹤0.01% 4679
2022
Q3
Sell
-1,600
Closed -$335K 10336
2022
Q2
$335K Sell
1,600
-15,000
-90% -$3.19M ﹤0.01% 7426
2022
Q1
$4.03M Sell
16,600
-3,600
-18% -$871K ﹤0.01% 3411
2021
Q4
$5.26M Buy
20,200
+2,800
+16% +$727K ﹤0.01% 2775
2021
Q3
$4.59M Sell
17,400
-6,100
-26% -$1.67M ﹤0.01% 2881
2021
Q2
$5.79M Buy
23,500
+19,500
+488% +$4.1M ﹤0.01% 2419
2021
Q1
$776K Sell
4,000
-7,300
-65% -$1.46M ﹤0.01% 5960
2020
Q4
$2.4M Sell
11,300
-3,900
-26% -$778K ﹤0.01% 3183
2020
Q3
$2.61M Sell
15,200
-4,600
-23% -$849K ﹤0.01% 2639
2020
Q2
$3.8M Buy
19,800
+11,900
+151% +$1.95M ﹤0.01% 2186
2020
Q1
$1.16M Buy
+7,900
New +$1.26M ﹤0.01% 2623
2019
Q1
Sell
-3,500
Closed -$399K 5528
2018
Q4
$399K Buy
+3,500
New +$375K ﹤0.01% 3723

Other funds holding RMD

Jane Street's RMD Position: Q1 2026 in Review

Jane Street increased its ResMed (RMD) stake by 27% in Q1 2026, buying an estimated $407K and bringing the position to 7,589 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #5398.

Jane Street first reported a position in RMD in Q2 2013 and has held it in 42 quarters since. The position peaked at $91.2M in Q4 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Jane Street held 7,589 shares of ResMed worth $1.7M as of Q1 2026.
  • Jane Street bought 1,634 ResMed shares in Q1 2026, an estimated $407K.
  • ResMed made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5398 holding.
  • Jane Street first reported a position in ResMed in Q2 2013 and has held it in 42 quarters since.
  • Jane Street's ResMed position peaked at $91.2M in Q4 2023.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.